0
Home
News
Directory
E-newsletter
Magazine
Events
Data
AgReport
Subscribe
Monsanto’s biological seed treatment Acceleron B-360 ST approved in USA
Apr. 5, 2018
Monsanto Company
United StatesFollow
United StatesThe BioAg Alliance — a collaboration between Novozymes and Monsanto Company — have referred to the project in the past as the Corn BioYield 2 poject and Acceleron B-360 ST. Acceleron B-360 ST will be used in combination with Acceleron B-300 SAT, which was introduced in 2017 and used by U.S. farmers on more than 4 million corn acres in its first year.
Acceleron B-360 ST is scheduled to enter the U.S. and Canadian markets in 2019, as well as select European and Middle East countries pending regulatory approval, according to a Monsanto spokesman.
AccoBiological seed treatments such as Acceleron B-300 SAT and Acceleron B-360 ST help plants build healthy root systems, which enable more efficient uptake of nutrients into the plant. The increase in nutrient uptake results in a decrease in the release of those nutrients into the environment, either via runoff into water supplies or into the air. The increases in plant biomass can help to sequester carbon into the soil, particularly in microbes that promote root development. The result is pulling carbon dioxide out of the air and storing it in the soil.
Source: Monsanto news release
More from AgroNews
Change
Hot TopicSubscribe
| Subscribe Email: | * | |
| Name: | ||
| Mobile Number: | ||
Comment
0/1200
NEWSLETTER